0
Special Feature
Blood pressure kiosks for medication therapy management programs: Business opportunity for pharmacists
Sherilyn K.D. Houle, BSP; Anderson W. Chuck, PhD, MPH; Ross T. Tsuyuki, BSc(Pharm), PharmD, MSc, FCSHP, FACC
J Am Pharm Assoc (2003) 2012;52:188-194. doi:10.1331/JAPhA.2012.11217

Abstract

Objectives  To develop an economic model based on the use of pharmacy-based blood pressure kiosks for case finding of remunerable medication therapy management (MTM) opportunities.

Design  Descriptive, exploratory, nonexperimental study.

Setting  Ontario, Canada, between January 2010 and September 2011.

Patients  More than 7.5 million blood pressure kiosk readings were taken from 341 pharmacies.

Intervention  A model was developed to estimate revenues achievable by using blood pressure kiosks for 1 month to identify a cohort of patients with blood pressure of 130/80 mm Hg or more and caring for those patients during 1 year.

Main outcome measure  Revenue generated from MTM programs.

Results  Pharmacies could generate an average of $12,270 (range $4,523–24,420) annually in revenue from billing for MTM services.

Conclusion  Blood pressure kiosks can be used to identify patients with elevated blood pressure who may benefit from reimbursable pharmacist cognitive services. Revenue can be reinvested to purchase automated dispensing technology or offset pharmacy technician costs to free pharmacists to provide pharmaceutical care. Improved patient outcomes, increased patient loyalty, and improved adherence are additional potential benefits.

Sign In
APhA Members 
Welcome to JAPhA.org! Please log in below using your APhA username and password. Update your APhA profile.
Not a Subscriber
New to JAPhA? Become an APhA member to receive a full subscription to both the print and online editions.

OR

Register for a FREE limited account to benefit from personalization features such as alerts.

References

Keenan NL, Rosendorf KA.  Prevalence of hypertension and controlled hypertension: United States, 2005-2008.  MMWR Surveill Summ. 2011;60(suppl):94–7. [PubMed]
 
Egan BM, Zhao Y, Axon RN.  US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008.  JAMA. 2010;303:2043–50. [PubMed][CrossRef]
 
Wilkins K, Campbell NR, Joffres MR, et al. Blood pressure in Canadian adults.  Health Rep. 2010;21:37–46. [PubMed]
 
World Health Organization. Global health risks: mortality and burden of disease attributable to selected major risks. Geneva:  World Health Organization; 2009:9–12.
 
Centers for Medicare & Medicaid Services. 2011 Medicare Part D Medication Therapy Management (MTM) programs: fact sheet. Accessed at www.cms.gov/PrescriptionDrugCovContra/Downloads/MTMFactSheet2011063011Final.pdf, September 21,  2011.
 
McLean DL, McAlister FA, Johnson JA, et al. A randomized trial of the effect of community pharmacist and nurse care on improving blood pressure management in patients with diabetes mellitus: Study of Cardiovascular Risk Intervention by Pharmacists–Hypertension (SCRIP-HTN).  Arch Intern Med. 2008;168:2355–61. [PubMed][CrossRef]
 
Santschi V, Chiolero A, Burnand B, et al. Impact of pharmacist care in the management of cardiovascular disease risk factors.  Arch Intern Med. 2011;171:1441–53. [PubMed][CrossRef]
 
Morgado MP, Morgado SR, Mendes LC, Pereira LJ, et al. Pharmacist interventions to enhance blood pressure control and adherence to antihypertensive therapy: review and meta analysis.  Am J Health Syst Pharm. 2011;68:241–53. [PubMed][CrossRef]
 
Chan P, Grindrod KA, Bougher D, et al. A systematic review of remuneration systems for clinical pharmacy care services.  Can Pharm J. 2008;141:102–12. [CrossRef]
 
Kassamali A, Houle S, Rosenthal M, Tsuyuki RT.  Case finding: the missing link in chronic disease management.  Can Pharm J. 2011;144:170–2. [CrossRef]
 
Ontario Ministry of Health and Long-Term Care. MedsCheck. Accessed at www.health.gov.on.ca/en/pro/programs/drugs/medscheck/medscheck_original.aspx, October 25,  2011.
 
Ontario Ministry of Health and Long-Term Care:  Pharmaceutical Opinion program. Accessed at www.health.gov.on.ca/en/pro/programs/drugs/pharmaopinion, October 25,  2011.
 
Statistics Canada. 2006 Census data products. Accessed at www12.statcan.ca/census-recensement/2006/dp-pd/index-eng.cfm, October 25,  2011.
 
Hux JE, Tang M.  Patterns of prevalence and incidence of diabetes. Accessed at www.ices.on.ca/file/DM_Chapter1.pdf, October 25,  2011.
 
Canadian Institute for Health Information. Seniors and prescription drug use. Accessed at www.cihi.ca/CIHI-ext-portal/pdf/internet/seniors_drug_info_en, October 25,  2011.
 
Stagnitti MN.  Average number of total (including refills) and unique prescriptions by select person characteristics, 2006. Statistical brief no. 245. Rockville, MD:  Agency for Healthcare Research and Quality;  2009.
 
Canadian Diabetes Association. Canadian Diabetes Association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada. Accessed at www.diabetes.ca/files/cpg2008/cpg-2008.pdf, December 17,  2011.
 
Rabi DM, Daskalpoulo SS, Padwal RS, et al. The 2011 Canadian Hypertension Education Program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy.  Can J Cardiol. 2011;27:415–33. [PubMed][CrossRef]
 
Statistics Canada. Canadian Community Health Survey, 2007-2008, cycle 4.1. Ottawa, Canada:  Statistics Canada;  2009.
 
Drummond MF, Sculpher MJ, Torrance GW, et al. Economic evaluation using decision analytic modeling. In: Methods for the economic evaluation of health care programmes. 3rd ed. New York:  Oxford University Press;  2005.
 
Briggs A, Sculpher M, Buxton M.  Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis.  Health Econ. 1994;3:95–104. [PubMed][CrossRef]
 
Canadian Pharmacists Association Management Committee. Moving forward: pharmacy human resources for the future: final report. Ottawa, Canada:  Canadian Pharmacists Association;  2008.
 
Rosenthal M, Austin Z, Tsuyuki RT.  Are pharmacists the ultimate barrier to pharmacy practice change? Can Pharm J. 2010;143:37–42. [CrossRef]
 
Banahan BF, Holmes ER.  A model to estimate increase in revenue from implementing medication adherence management services in community pharmacies [abstract].  Value Health 2010;13(3):A93. [CrossRef]
 
Lewis JE, Boyle E, Magharious L, Myers MG.  Evaluation of a community-based automated blood pressure measuring device.  CMAJ. 2002;166:1145–8. [PubMed]
 
Wiggers-Porta ME, Ruisinger JF, Hare SE, et al. Accuracy and pharmacist perceptions of community-based automated blood pressure machines.  J Am Pharm Assoc. 2011;51:454–5. [CrossRef]
 
Alpert BS.  Validation of the Pharma-Smart PS-2000 public use blood pressure monitor. Blood Press Monit. 2004;9:19–23.
 
Ontario Ministry of Health and Long-Term Care. Pharmacy smoking cessation program. Accessed at www.health.gov.on.ca/en/pro/programs/drugs/smoking/, October 29,  2011.
 
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Please read the other comments before you post yours. Comments are moderated and will appear on the site at the discertion of the editorial staff.
* = Required Field
(if multiple authors, separate names by comma)
Example: John Doe



Related Content

Customize your page view by dragging & repositioning the boxes below.

JAPhA Articles
Topic Collections
PubMed Articles
Advertisement
 
  • Print
  • PDF Download
  • Email
  • Share
  • Get Citation
  • Submit Comment
  • Article Alerts
    Please Wait... Processing your request... Please Wait.
    You must sign in to sign-up for alerts.

    Please confirm that your email address is correct, so you can successfully receive this alert.

  • Letters To Editor
  • Reprints